|
13 Jul 2020 |
Tonix Pharmaceuticals Enters into Research and Exclusive License Option Agreement with Kansas State University to Develop Vaccine Against COVID-19
|
|
13 Jul 2020 |
Pfizer and BioNTech Granted FDA Fast Track Designation for Two Investigational mRNA-based Vaccine Candidates Against SARS-CoV-2
|
|
08 Jul 2020 |
CEPI Expands Partnership with Clover Biopharmaceuticals to Rapidly Advance Development and Manufacture of COVID-19 Vaccine Candidate
|
|
08 Jul 2020 |
Novavax Announces $1.6 Billion Funding from Operation Warp Speed
|
|
07 Jul 2020 |
GSK and Medicago announce collaboration to develop a novel adjuvanted COVID-19 candidate vaccine
|
|
07 Jul 2020 |
Sinovac COVID-19 Vaccine Collaboration with Butantan Receives Approval from Brazilian Regulator for Phase III Trial
|
|
02 Jul 2020 |
Sorrento Announces Selection of T-VIVA-19™ as Targeted Protein Vaccine Candidate for SARS-CoV-2
|
|
01 Jul 2020 |
Johnson & Johnson Announces European Commission Approval for Janssen’s Preventive Ebola Vaccine
|
|
01 Jul 2020 |
Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 Study of mRNA-based Vaccine Candidate Against SARS-CoV-2
|
|
30 Jun 2020 |
Meissa Vaccines Provides a Pipeline Update on Vaccine Candidates for COVID-19 and RSV
|
|
30 Jun 2020 |
INOVIO Announces Positive Interim Phase 1 Data For INO-4800 Vaccine for COVID-19
|
|
26 Jun 2020 |
Entos Pharmaceuticals Announces Selection of Lead DNA Vaccine Candidates for COVID-19 and a $4.2M Award to Move Forward with Phase I/II Human Trials
|
|
26 Jun 2020 |
ERC Belgium Submits Marketing Authorization Application to European Medicines Agency (EMA) for Glioblastoma Immunotherapy, SITOIGANAP
|
|
25 Jun 2020 |
Sinovac Receives Approval from China for its Quadrivalent Influenza Vaccine
|
|
24 Jun 2020 |
Immunovative Therapies and Mirror Biologics Announce US FDA Clearance of a Universal Anti-Viral Vaccine Phase I/II Clinical Trial for Healthy Elderly Adults
|
|
23 Jun 2020 |
Sanofi and Translate Bio Expand Collaboration to Develop mRNA Vaccines Across All Infectious Disease Areas
|
|
23 Jun 2020 |
First Participant Dosed in Phase 1 Clinical Study with VTP-300 Immunotherapeutic to Treat Chronically Infected Hepatitis B Patients
|
|
23 Jun 2020 |
Collaborative COVID-19 Vaccine Project Between ImmunoPrecise Antibodies Europe and LiteVax BV, Funded Through TRANSVAC2
|
|
22 Jun 2020 |
Merck Announces That V114, Its Investigational 15-valent Pneumococcal Conjugate Vaccine, Met Safety and Immunogenicity Objectives in Initial Phase 3 Studies in Adults
|
|
22 Jun 2020 |
Pfizer Announces Start of Four Phase 3 Clinical Trials for Investigational Vaccines
|
|
22 Jun 2020 |
VBI Vaccines Announces Data from VBI-1901 Presented at AACR 2020: Partial Response Observed, Promising Biomarker Strategy Identified
|
|
22 Jun 2020 |
50% Complete Response Rate Observed in YourVaccx™ Study for Patients with Metastatic Prostate Cancer was Presented at the AACR Virtual Annual Meeting II
|
|
20 Jun 2020 |
Clover Biopharmaceuticals Initiates Phase 1 Clinical Trial for COVID-19 Vaccine Candidate
|
|
18 Jun 2020 |
Codagenix Announces the Synthesis and Preliminary Safety of Scalable, Live-attenuated Vaccine Candidate Against COVID-19
|
|
18 Jun 2020 |
CureVac Receives Regulatory Approval from German and Belgian Authorities to Initiate Phase 1 Clinical Trial of its SARS-CoV-2 Vaccine Candidate
|
